Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Evodiamine Derivative. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108794474B reveals novel evodiamine derivatives targeting Top1/Top2/HDAC. Enhances supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Novel bis-evodiamine derivatives with enhanced antitumor activity and scalable synthesis routes for pharmaceutical intermediates supply chain optimization.